Induced pluripotent stem cell-derived extracellular vesicles: A novel approach for cell-free regenerative medicine.
Behnaz TaheriMasoud SoleimaniSedigheh Fekri AvalElaheh EsmaeiliZahra BaziNosratollah ZarghamiPublished in: Journal of cellular physiology (2018)
In recent years, induced pluripotent stem cells (iPSCs) have been considered as a promising approach in the field of regenerative medicine. iPSCs can be generated from patients' somatic cells and possess the potential to differentiate, under proper conditions, into any cell type. However, the clinical application of iPS cells is restricted because of their tumorigenic potential. Recent studies have indicated that stem cells exert their therapeutic benefit via a paracrine mechanism, and extracellular vesicles have been demonstrated that play a critical role in this paracrine mechanism. Due to lower immunogenicity, easier management, and presenting no risk of tumor formation, in recent years, researchers turned attention to exosomes as potential alternatives to whole-cell therapy. Application of exosomes derived from iPSCs and their derived precursor provides a promising approach for personalized regenerative medicine. This study reviews the physiological functions of extracellular vesicles and discusses their potential therapeutic benefit in regenerative medicine.
Keyphrases
- induced pluripotent stem cells
- stem cells
- cell therapy
- induced apoptosis
- cell free
- mesenchymal stem cells
- cell cycle arrest
- newly diagnosed
- ejection fraction
- endoplasmic reticulum stress
- signaling pathway
- prognostic factors
- randomized controlled trial
- gene expression
- oxidative stress
- endothelial cells
- diabetic rats
- high glucose
- dna methylation
- patient reported outcomes
- patient reported
- drug induced